Patients with idiopathic pulmonary fibrosis have poor clinical outcomes with COVID-19 disease: a propensity matched multicentre research network analysis.

Syeda Fatima Naqvi Dhairya A LakhaniAmir Humza SohailJames MaurerSarah SofkaArif SarwariYousaf B Hadi

Published in: BMJ open respiratory research (2021)

Poor outcomes of COVID-19 disease were observed in patients with IPF after robust matching of confounders. Our data confirm that patients with IPF constitute a high-risk cohort for poor outcomes related to COVID-19 disease.

Keyphrases

idiopathic pulmonary fibrosis
coronavirus disease
sars cov
network analysis
interstitial lung disease
clinical trial
type diabetes
systemic sclerosis
respiratory syndrome coronavirus
electronic health record
metabolic syndrome
skeletal muscle
adipose tissue
weight loss
double blind